spacer
home > pmps > spring 2019 > digitising the chain
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Digitising the Chain

The pharmaceutical and medical supplies sector, like every other, has changed almost beyond recognition in the past decade, thanks to the development and availability of data-driven systems. For example, artificial intelligence is widely seen as the next frontier in R&D, helping to speed up clinical trials, improve their validity, and get drugs to market sooner.

Production, warehousing, and distribution have undergone a similar transition, with automation and data insights increasingly being used to speed up processes and improve traceability and compliance. Digital processes now impact every aspect of the modern supply chain, from Tier 1 drugs manufacturers to smallmedium enterprises supplying sterile packaging or components.

System Selection

Agile systems enable pharma companies to meet the requirements and challenges of a rapidly evolving sector. The availability of real-time data means production managers can make better informed decisions, moving from merely reporting what is happening on the shop floor to driving positive action. Its application is akin to researchers conducting clinical trials using data from multiple sources, such as wearable technology, rather than relying on limited and/or historic results to deliver more rigorous results faster.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Rod Schregardus is a Consultant Manager at pharma software expert, Access Group. Specialising in global new business for Access’ advanced planning and scheduling software, Access Orchestrate, Rod boasts over 20 years in the manufacturing industry and works with pharma companies across the world.
spacer
Rod Schregardus
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers
 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement